The RAF/MEK/ERK signaling cascade is a key mediator of neurotrophin signaling via Trks and is among the most studied signaling cascades in all of biological sciences. In the nervous system, RAF/MEK/ERK signaling is thought to regulate morphological development, differentiation, and neuronal plasticity in response to extracellular signals. Despite its presumed importance, the role of RAF/MEK/ERK signaling in nervous system development and function in vivo is largely unknown due to the fact that the initial round of gene targeted animals has not been informative. We propose a conditional mutagenesis approach to testing the roles of RAF/MEK/ERK signaling on axon growth, differentiation, and regeneration using dorsal root ganglion (DRG) neurons as a model system. Specifically, we propose to test the following five hypotheses: /. RAF kinase signaling regulates morphological development but not survival of DRG neurons. II. RAF kinase signaling regulates differentiation of DRG neurons. III. RAF kinase signaling is required for efficient axon regeneration after peripheral axotomy. IV. Conditional elimination of MEKs will yield phenotypes discordant from those produced by conditional elimination of RAFs V Conditional elimination of ERKs will yield phenotypes discordant from those produced by elimination of RAFs and those produced by elimination of MEKs. Defining the biological roles of the RAF/MEK/ERK cascade using conditional gene targeting in mice will provide key insights into the regulation of axon growth, neuronal differentiation and regeneration. The results will also speak to the likely efficacy and potential toxicity of the many drugs being developed to inhibit functions of this cascade for the treatment of neural tumors and chronic pain states. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS031768-14
Application #
7145106
Study Section
Neurodifferentiation, Plasticity, and Regeneration Study Section (NDPR)
Program Officer
Mamounas, Laura
Project Start
1993-04-07
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
14
Fiscal Year
2007
Total Cost
$403,325
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Neurology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hutton, Scott R; Otis, James M; Kim, Erin M et al. (2017) ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions. J Neurosci 37:8102-8115
Xing, Lei; Larsen, Rylan S; Bjorklund, George Reed et al. (2016) Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex. Elife 5:
Xing, Lei; Li, Xiaoyan; Snider, William D (2015) Neurodevelopment. ""RASopathic"" astrocytes constrain neural plasticity. Science 348:636-7
Meechan, Daniel W; Maynard, Thomas M; Tucker, Eric S et al. (2015) Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development. Prog Neurobiol 130:1-28
Yi, Jason J; Berrios, Janet; Newbern, Jason M et al. (2015) An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A. Cell 162:795-807
Xing, Lei; Newbern, Jason M; Snider, William D (2013) Neuronal development: SAD kinases make happy axons. Curr Biol 23:R720-3
Maynard, Thomas M; Gopalakrishna, Deepak; Meechan, Daniel W et al. (2013) 22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development. Hum Mol Genet 22:300-12
Li, Xiaoyan; Newbern, Jason M; Wu, Yaohong et al. (2012) MEK Is a Key Regulator of Gliogenesis in the Developing Brain. Neuron 75:1035-50
Meechan, Daniel W; Tucker, Eric S; Maynard, Thomas M et al. (2012) Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc Natl Acad Sci U S A 109:18601-6
Meechan, D W; Maynard, T M; Tucker, E S et al. (2011) Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes. Int J Dev Neurosci 29:283-94

Showing the most recent 10 out of 45 publications